SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,815.00    120.00 (1.79%)
Bid:
6,820.00
Ask:
6,830.00
Spread: 10.00 (0.147%)
Market Cap: £5.03b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Acquisition

30 Nov 2016 07:00

RNS Number : 4634Q
Spirax-Sarco Engineering PLC
30 November 2016
 

 

30th November 2016

Spirax Sarco acquires Aflex Hose Limited for £61.4 million

Spirax-Sarco Engineering plc (Spirax Sarco), the world leader in the control and efficient use of steam, and in peristaltic pumping and associated fluid path technologies, announces that it has acquired Aflex Hose Limited and its subsidiary Aflex Hose USA LLC (Aflex) for £61.4 million. 

Aflex, based in Halifax, UK and with a sales and assembly operation in Pennsylvania, USA, specialises in the design and manufacture of PTFE-lined flexible hoses for the pharmaceutical, food, chemical and automotive industries. The business will be integrated into the Watson-Marlow Fluid Technology Group (WMFTG). We are pleased that Rod Anderson, a founder, will continue as a technical advisor and that senior management will remain with the business.

Aflex is highly synergistic with, and a natural extension to, the WMFTG fluid path product portfolio and further strengthens WMFTG's already strong global presence in the biotechnology, pharmaceutical, industrial, chemical and food & beverage sectors. Aflex utilises patented, market-leading technology to produce PTFE-lined flexible hoses, which outperform other PTFE and standard hose types within the most demanding applications, ensuring the highest levels of chemical resistance, superior flexibility and sterility. Aflex's premium PTFE-lined hoses complement our FlowSmart silicone hoses and WMFTG's other fluid path products, as part of our strategy to provide a complete value-added hose and tubing range.

The Aflex brand has a well-established worldwide reputation and the company had net sales of over £23 million in their last financial year, ended August 2016, with underlying EBITDA of £6 million. Post completion, Spirax Sarco will invest in Aflex to further develop its products and routes to market.

The purchase consideration is on a debt free and cash free basis, and will be financed from Spirax Sarco's existing resources. The acquisition will have a negligible impact on Group earnings in the current year but is expected to be a positive contributor from 2017 onwards.

Enquiries:

Nicholas Anderson, Chief Executive

Kevin Boyd, Group Finance Director

Tel: 01242 535234

 

About Spirax Sarco

 

Spirax-Sarco Engineering plc is the world leader in each of its two businesses, Spirax Sarco for steam specialties and Watson‑Marlow Fluid Technology Group for niche peristaltic pumps and associated fluid path technologies. The steam specialties business provides a broad range of fluid control products, engineered packages, site services and systems expertise for a diverse range of industrial and institutional customers. The company helps its customers to improve production efficiency, reduce energy costs, water usage and emissions, improve product quality and enhance the safety of their operations. Watson-Marlow Fluid Technology Group offers the ideal solution for a wide variety of demanding fluid path applications with highly accurate, controllable and virtually maintenance free pumps and associated technologies. The Group is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs approximately 5,000 people, of whom around 1,300 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX).

 

Further information can be found at www.spiraxsarcoengineering.com 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEASFNASXKFFF
Date   Source Headline
25th Nov 200512:22 pmRNSHolding(s) in Company
17th Nov 200510:00 amRNSAdditional Listing
11th Nov 20055:03 pmRNSDirector/PDMR Shareholding
10th Nov 20053:48 pmRNSDirector/PDMR Shareholding
26th Oct 20054:18 pmRNSDirector/PDMR Shareholding
12th Oct 20053:40 pmRNSAdditional Listing
11th Oct 200511:00 amRNSDirector/PDMR Shareholding
7th Oct 20051:56 pmRNSDirector/PDMR Shareholding
4th Oct 20059:55 amRNSDirector/PDMR Shareholding
30th Sep 20054:22 pmRNSDirector/PDMR Shareholding
9th Sep 20055:11 pmRNSDirector/PDMR Shareholding
9th Sep 20054:17 pmRNSDirector/PDMR Shareholding
6th Sep 20057:00 amRNSInterim Results
4th Aug 200511:31 amRNSHolding(s) in Company
2nd Aug 200510:33 amRNSNotice of Results
28th Jul 20054:46 pmRNSHolding(s) in Company
12th Jul 20059:30 amRNSIFRS Statement
28th Jun 20055:10 pmRNSAdditional Listing
27th Jun 200510:20 amRNSAcquisition
24th Jun 20053:50 pmRNSDirector Shareholding
20th Jun 20055:13 pmRNSDirector Shareholding
9th Jun 20051:56 pmRNSAcquisition
27th May 200512:34 pmRNSAdditional Listing
26th May 20058:30 amRNSDirector Shareholding
25th May 20055:11 pmRNSDirector Shareholding
24th May 20054:54 pmRNSDirector Shareholding
20th May 20055:26 pmRNSDirector Shareholding
12th May 20052:10 pmRNSAGM Statement
29th Apr 20054:25 pmRNSDirector Shareholding
26th Apr 200511:11 amRNSHolding(s) in Company
18th Apr 20055:50 pmRNSHolding(s) in Company
4th Apr 20054:03 pmRNSAdditional Listing
29th Mar 20053:40 pmRNSDirector Shareholding
24th Mar 200511:26 amRNSDirector Shareholding
23rd Mar 20055:23 pmRNSDirector Shareholding
17th Mar 20054:56 pmRNSDirector Shareholding
14th Mar 20054:32 pmRNSDirector Shareholding
14th Mar 20057:00 amRNSFinal Results
25th Feb 20054:29 pmRNSHolding(s) in Company
16th Feb 20051:55 pmRNSBoard Membership Changes
17th Jan 20055:19 pmRNSHolding(s) in Company
12th Jan 20059:15 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.